ஆஸ்துமா அறிகுறி டைரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆஸ்துமா அறிகுறி டைரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆஸ்துமா அறிகுறி டைரி Today - Breaking & Trending Today

New Medication Reduces Asthma Exacerbations and Improves Lung Function in Patients with Severe, Uncontrolled Asthma


New Medication Reduces Asthma Exacerbations and Improves Lung Function in Patients with Severe, Uncontrolled Asthma
Share Article
Results from the phase 3 NAVIGATOR study was presented during the 2021 AAAAI Virtual Annual Meeting.
Tezepelumab has the potential to transform treatment for a broad population of patients with severe asthma irrespective of their type of inflammation, including those with and without an eosinophilic phenotype.”
MILWAUKEE (PRWEB)
February 26, 2021
Tezepelumab, a human monoclonal antibody, was found to be effective for patients with severe uncontrolled asthma in a phase 3 trial funded by AstraZeneca and Amgen, Inc. Data from the abstract was presented during the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) Virtual Annual Meeting. ....

United States , United Kingdom , City Of , Jonathan Corren , Andrew Menzies Gow , Imperial College London , Amgen Inc , Lung Division , American Academy Of Allergy , Virtual Annual , Asthma Control , Asthma Quality , Asthma Symptom Diary , Royal Brompton Hospital , Respiratory Medicine , Imperial College , American Academy , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஜொனாதன் கார்ரேன் , ஆண்ட்ரூ மென்ஸீஸ் கௌ , ஏகாதிபத்தியம் கல்லூரி லண்டன் , மகேன் இன்க் , நுரையீரல் பிரிவு , அமெரிக்கன் கலைக்கழகம் ஆஃப் ஒவ்வாமை ,